Capillary Technology Posts Rs 184 Cr Revenue in Q3 FY26; Profit Falls 20%

Capillary Technology Posts Rs 184 Cr Revenue in Q3 FY26; Profit Falls 20%

Entrackr
EntrackrFeb 6, 2026

Why It Matters

The results highlight Capillary’s ability to grow revenue in a competitive SaaS market while grappling with rising cost structure, a key signal for investors evaluating post‑IPO sustainability.

Key Takeaways

  • Revenue rose 16% YoY to Rs 184 crore.
  • Profit fell 20% to Rs 8 crore.
  • Employee benefits cost 22% increase, half of expenses.
  • Market cap reached Rs 4,857 crore after debut.
  • Stock rose to Rs 612, trading above issue price.

Pulse Analysis

Capillary Technologies’ third‑quarter FY26 earnings illustrate a classic growth‑versus‑profitability trade‑off common among fast‑scaling SaaS firms. Revenue climbed to Rs 184 crore, driven by expanding loyalty and CRM contracts across 390 brands in 46 countries. However, the profit margin contracted as employee benefit expenses—now Rs 90 crore—rose 22% and consumed roughly 50% of total outlays. This cost profile reflects the company’s aggressive talent acquisition strategy, a necessary investment to sustain product innovation and global customer support, but it also pressures bottom‑line performance.

The Indian SaaS sector continues to attract capital, with enterprises seeking cloud‑native customer engagement platforms to boost retention. Capillary’s focus on loyalty and omnichannel CRM positions it well against rivals such as Zoho and Freshworks, especially as retailers and FMCG firms accelerate digital transformation. The 22% nine‑month revenue growth to Rs 543 crore signals robust demand, yet the firm must balance scaling costs with margin improvement to compete on both price and functionality. Analysts are watching whether Capillary can leverage its international footprint to diversify revenue streams and achieve economies of scale.

Capillary’s market debut was modest, listing at a 3% discount to the issue price and closing the day at Rs 612, lifting its market cap to Rs 4,857 crore. The post‑IPO price action suggests cautious optimism among investors, who are weighing the company’s top‑line traction against its widening expense base. Going forward, sustained revenue acceleration, disciplined cost management, and strategic upselling to existing clients will be critical for the firm to justify its valuation and deliver shareholder value.

Capillary Technology posts Rs 184 Cr revenue in Q3 FY26; profit falls 20%

Comments

Want to join the conversation?

Loading comments...